Weight change associated with third generation adjuvant chemotherapy in breast cancer patients

Journal of Community and Supportive Oncology

Volumn 12, Issue 10, 2014, Pages 355-360

  Chaudhary, Lubna N ^a,b   Wen, Sijin ^c   Xiao, Jie ^c   Swisher, Anne K ^d   Kurian, Sobha ^b   Abraham, Jame ^b,e  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Section of Hematology Oncology   (United States)

^c Department of Biostatistics ^*  (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BEVACIZUMAB; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PACLITAXEL; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADULT; AREA UNDER THE CURVE; BODY WEIGHT; BREAST CANCER; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; KAPLAN MEIER METHOD; KRUSKAL WALLIS TEST; LOADING DRUG DOSE; LOG RANK TEST; LUMPECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; MENOPAUSE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; POST HOC ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; RECURRENCE FREE SURVIVAL; RISK FACTOR; SIDE EFFECT; TREATMENT DURATION; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; WEST VIRGINIA;

EID: 84989201382     PISSN: 23307749     EISSN: None     Source Type: Journal    
DOI: 10.12788/jcso.0078     Document Type: Conference Paper

References (37)

1. World Health Organization. Obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/. Updated august 2014. Accessed October 13, 2013.
2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Bodymass index and incidence of cancer: a systematic review and metaanalysis of prospective observational studies. Lancet. 2008;371:569-578.
3. American Cancer Society. Breast cancer facts and figures. http://www.cancer.org/research/cancerfactsstatistics/breast-cancer-factsfigures. Updated 2012-2013.Accessed October 13, 2013.
4. Cheney CL, Mahloch J, Freeny P. Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr. 1997;66:141-146.
5. DeGeorge D, Gray JJ, Fetting JH, Rolls BJ. Weight gain in patients with breast cancer receiving adjuvant treatment as a function of restraint, disinhibition, and hunger. Oncol Nurs Forum. 1990;17(3 Suppl):23-8; discussion 28-30.
6. Dixon JK, Moritz DA, Baker FL. Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum. 1978;5:5-7.
7. Foltz AT. Weight gain among stage II breast cancer patients: A study of five factors. Oncol Nurs Forum. 1985;12:21-26.
8. Huntington MO. Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer. 1985;56:472-474.
9. Knobf MK, Mullen JC, Xistris D, Moritz DA. Weight gain in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 1983;10:28-33.
10. Goodwin PJ. Weight gain in early-stage breast cancer: Where do we go from here? J Clin Oncol. 2001;19:2367-2369.
11. Levine EG, Raczynski JM, Carpenter JT. Weight gain with breast cancer adjuvant treatment. Cancer. 1991;67:1954-1959.
12. Goodwin PJ, Ennis M, Pritchard KI, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol. 1999;17:120-129.
13. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19:2381-2389.
14. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc. 1997;97:519-526,529; quiz 527-8.
15. Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd NF. Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 1985;5:195-200.
16. Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA. Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat. 1999;57:285-290.
17. Irwin ML, McTiernan A, Baumgartner RN, et al. Changes in body fat and weight after a breast cancer diagnosis: Influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005;23:774-782.
18. Makari-Judson G, Judson CH, Mertens WC. Longitudinal patterns of weight gain after breast cancer diagnosis: Observations beyond the first year. Breast J. 2007;13:258-265.
19. Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1993;11:1418-1429.
20. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist. 2004;9:606-616.
21. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplifcation of the HER-2/neu oncogene. Science. 1987;235:177-182.
22. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514-527.
23. Berclaz G, Li S, Price KN, et al. Body mass index as a prognostic feature in operable breast cancer: Te international breast cancer study group experience. Ann Oncol. 2004;15:875-884.
24. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The iowa women's health study. Cancer. 1995;76:275-283.
25. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001;92:720-729.
26. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: A review of the evidence. J Clin Oncol. 2002;20:3302-3316.
27. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20:1128-1143.
28. Petrelli JM, Calle EE, Rodriguez C, Tun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control. 2002;13:325-332.
29. Loi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1686-1691.
30. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2005;14:2009-2014.
31. Cleveland RJ, Eng SM, Abrahamson PE, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1803-1811.
32. Protani M, Coory M, Martin JH. Efect of obesity on survival of women with breast cancer: Systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627-635.
33. Sparano JA, Wang M, Zhao F, et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer. 2012;118:5937-5946.
34. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-591.
35. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23:1370-1378.
36. Chlebowski RT, Blackburn GL, Tomson CA, et al. Dietary fat reduction and breast cancer outcome: Interim efcacy results from the women's intervention nutrition study. J Natl Cancer Inst. 2006;98:1767-1776.
37. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fber and low in fat on prognosis following treatment for breast cancer: Te women's healthy eating and living (WHEL) randomized trial. J Am Med Assoc. 2007;298:289-298.